| Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica MR Ajmera, A Boscoe, J Mauskopf, SD Candrilli, M Levy Journal of the neurological sciences 384, 96-103, 2018 | 102 | 2018 |
| Prescription drug use and polypharmacy among Medicaid-enrolled adults with autism: A retrospective cross-sectional analysis R Vohra, S Madhavan, U Sambamoorthi, C StPeter, S Poe, N Dwibedi, ... Drugs-real world outcomes 3, 409-425, 2016 | 40 | 2016 |
| A real‐world study of the effect of timing of insulin initiation on outcomes in older Medicare beneficiaries with type 2 diabetes mellitus R Bhattacharya, S Zhou, W Wei, M Ajmera, U Sambamoorthi Journal of the American Geriatrics Society 63 (5), 893-901, 2015 | 33 | 2015 |
| Perception of cancer recurrence risk: more information is better KM Kelly, M Ajmera, S Bhattacharjee, R Vohra, G Hobbs, L Chaudhary, ... Patient education and counseling 90 (3), 361-366, 2013 | 33 | 2013 |
| Dual Medicare and Veteran Health Administration use and ambulatory care sensitive hospitalizations M Ajmera, TL Wilkins, U Sambamoorthi Journal of general internal medicine 26, 669-675, 2011 | 31 | 2011 |
| Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary … M Ajmera, AD Raval, C Shen, U Sambamoorthi International journal of chronic obstructive pulmonary disease, 339-348, 2014 | 30 | 2014 |
| Multimorbidity, mental illness, and quality of care: preventable hospitalizations among medicare beneficiaries M Ajmera, TL Wilkins, PA Findley, U Sambamoorthi International Journal of Family Medicine 2012, 2012 | 28 | 2012 |
| Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults R Bhattacharya, M Ajmera, S Bhattacharjee, U Sambamoorthi Diabetes research and clinical practice 105 (2), 251-260, 2014 | 24 | 2014 |
| A real-world observational study of time to treatment intensification among elderly patients with inadequately controlled type 2 diabetes mellitus M Ajmera, A Raval, S Zhou, W Wei, R Bhattacharya, C Pan, ... Journal of managed care & specialty pharmacy 21 (12), 1184, 2015 | 23 | 2015 |
| Treatment intensification in type 2 diabetes: a real-world study of 2-OAD regimens, GLP-1 RAs, or basal insulin L Blonde, D Raccah, E Lew, J Meyers, E Nikonova, M Ajmera, KL Davis, ... Diabetes Therapy 9, 1169-1184, 2018 | 20 | 2018 |
| Multimorbidity and COPD medication receipt among Medicaid beneficiaries with newly diagnosed COPD M Ajmera, U Sambamoorthi, A Metzger, N Dwibedi, G Rust, C Tworek Respiratory care 60 (11), 1592-1602, 2015 | 20 | 2015 |
| Association between statin medications and COPD-specific outcomes: a real-world observational study M Ajmera, C Shen, U Sambamoorthi Drugs-real world outcomes 4, 9-19, 2017 | 14 | 2017 |
| Concomitant medication use and new-onset diabetes among medicaid beneficiaries with chronic obstructive pulmonary disease M Ajmera, C Shen, U Sambamoorthi Population Health Management 20 (3), 224-232, 2017 | 12 | 2017 |
| An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States CF Bell, MR Ajmera, J Meyers Lupus 31 (2), 202-211, 2022 | 11 | 2022 |
| A real-world analysis of relapses and costs of neuromyelitis optica spectrum disorders using a United States administrative claims database (P6. 161) D Stafkey-Mailey, A Boscoe, M Ajmera, J Mauskopf, U Iloeje, M Levy Neurology 86 (16_supplement), P6. 161, 2016 | 9 | 2016 |
| Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review F Passamonti, FH Heidel, RC Parikh, M Ajmera, D Tang, JA Nadal, ... Future Oncology 18 (18), 2217-2231, 2022 | 8 | 2022 |
| Use of antifungals and outcomes among inpatients at risk of invasive Aspergillosis or Mucormycosis in the USA: a retrospective cohort study K Stull, E Esterberg, M Ajmera, S Candrilli, TM Kitt, JR Spalding, VP Patel Infectious Diseases and Therapy 8, 641-655, 2019 | 8 | 2019 |
| What’s been the bang for the buck? Cost-effectiveness of health care spending across selected conditions in the US D Wamble, M Ciarametaro, K Houghton, M Ajmera, RW Dubois Health Affairs 38 (1), 68-75, 2019 | 8 | 2019 |
| Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs K Rajagopalan, SD Candrilli, M Ajmera ClinicoEconomics and Outcomes Research, 619-627, 2018 | 8 | 2018 |
| Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world … G Rocque, JL Blum, A Montero, I Nakhoul, S Kurian, RC Frank, B Telivala, ... 2019 San Antonio Breast Cancer Symposium (SABCS), San Antonio, TX, 2019 | 7 | 2019 |
Usha SambamoorthiWest Virginia University, School of PharmacyE-mail megerősítve itt: hsc.wvu.edu
